One of the persistent challenges with existing addiction medications is that patients stop taking them
While the thought of self-administering injections may seem daunting, our clients typically find they quickly become routine
Because of its impact on weight, retatrutide may become an option for adults with bodies with higher BMIs who may not have considered an injectable medication before, says Apovian
[1] Retatrutide (trials): once-weekly subcutaneous administration, starting low (e.g., 2 mg) and escalating to 4, 8, or 12 mg maintenance, with slower titration used to improve tolerability
Insulin, as a hormone replacement, does not have these potential anti-inflammatory applications